等待開盤 08-15 09:30:00 美东时间
-0.620
-4.34%
UBS analyst Manav Gupta maintains Calumet (NASDAQ:CLMT) with a Neutral and raises the price target from $12 to $13.25.
08-12 21:49
Calumet Specialty Products (($CLMT)) has held its Q2 earnings call. Read on for...
08-12 09:09
Companies Reporting Before The Bell • BeOne Medicines (NASDAQ:ONC) is expected ...
08-08 16:32
Calumet Specialty Prods (NASDAQ:CLMT) is preparing to release its quarterly ear...
08-07 23:06
Calumet Specialty Products ( ($CLMT) ) has shared an announcement. On July 25, ...
07-31 21:25
Calumet, Inc. (NASDAQ:CLMT) ("Calumet" or the "Company") announced today that it has extended its Shreveport terminal asset financing arrangement with Stonebriar Commercial Finance LLC ("Stonebriar"). This transaction
07-28 19:54
The latest announcement is out from Calumet Specialty Products ( ($CLMT) ). On ...
06-16 21:45
Calumet Specialty Products ( ($CLMT) ) has issued an announcement. On May 21, 2...
05-22 04:58
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1129333511617925121.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 蒙特利尔银行:维持Disc Medicine(IRON)"跑赢大市"评级,目标价从112美元升至120美元</p> <p>• 巴克莱:维持Karyopharm Therapeutics(KPTI)"超配"评级,目标价从5美
05-14 08:48